◆Tes= Acquired a domestic patent for substrate processing equipment and an O-ring cleaning method for substrate processing equipment.


◆Sillajen= Confirmed that the Seoul Southern District Prosecutors' Office has filed charges against the current CEO for breach of duty and attempted breach of duty.


◆Alteogen= Clarified that the rumors regarding "accounting fraud, etc." are "groundless."



◆MedPacto= Submitted an IND (Investigational New Drug) application to the Ministry of Food and Drug Safety for a Phase 2 clinical trial plan combining Betosertib and Keytruda as a first-line treatment for non-small cell lung cancer.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing